For most individuals with ADHD, symptoms persist at least into late adolescence and early adulthood—often much longer. For many, this disorder of the brain’s management system not only persists, it becomes more problematic during the inevitable challenges of early adulthood in which one has to manage much more for oneself. Yet, in the years of transition to adulthood, obtaining adequate assessment and treatment for ADHD is often more difficult than at any other point during the lifespan.

A small Texas pharmaceutical company that is building a sales and marketing headquarters in Blue Bell has won Food and Drug Administration approval for a first-of-a-kind treatment for Attention Deficit Hyperactivity Disorder in patients 6 years and older. Neos Therapeutics Inc. secured final FDA approval late Wednesday for Adzenys, the first oral tablet for ADHD that dissolves in the mouth in less than 30 seconds, and does not require swallowing a pill or capsule.

Although recent attention has focused on intentional or unintentional overdoses of ADHD medications, new research suggests the benefits of the drugs, including suicide reductions, are often overlooked.

Controversies in the news media have made many skeptical about A.D.H.D., and there are legitimate concerns about over-diagnosis and medication misuse when it comes to attention deficit disorders. But strong scientific evidence supports the biological basis of this disorder and shows the dire consequences it can have on health and well-being...Fortunately, behavioral interventions and medication can make a tremendous difference for children with A.D.H.D.

Do you misplace things? Are you easily distracted and often forget to complete tasks or attend appointments; or do you know someone who fits this description? Have you wondered if you have Attention Deficit Hyperactivity Disorder (ADHD)?...So how can you tell if you have adult ADHD?"

Although relatively common, ADHD in adults can be very difficult to diagnose and manage. Some of the challenges and barriers we face when diagnosing and treating ADHD in adults are obvious. For example, providers have concerns when prescribing stimulants, which are controlled substances. Other challenges are less obvious and require more skill to overcome, including newly updated diagnostic criteria, patients' utilization of compensatory mechanisms, and the subjective nature of the symptoms.